Enlarged Prostate News and Research

RSS

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

A widely used screening tool deployed in the early phases of drug discovery to weed out undesirable compounds is wrong so often it can't be trusted on its own, according to scientists at the University of North Carolina at Chapel Hill.

11 Jul 2017

Use of 5ARIs for prostatic enlargement not linked to increased suicide risk in older men

Using 5α- reductase inhibitors was not associated with increased suicide risk in a group of older men but risks for self-harm and depression were increased during the 18 months after medication initiation, although "the relatively small magnitude of these risks should not dissuade physicians from prescribing these medications in appropriate patients," according to an article published online by JAMA Internal Medicine.

20 Mar 2017

Remnant fetal tissue could contribute to enlarged prostate in later life

New research from Michigan State University indicates that embryonic tissue, key to the development of a baby's gender, could contribute to an enlarged prostate, or BPH, in men later in life.

14 Mar 2017

Prolonged exposure to male hormone blockers increases risk of persistent erectile dysfunction

Men with longer exposure to the drugs finasteride and dutasteride had a higher risk of getting persistent erectile dysfunction than men with less exposure, reports a new Northwestern Medicine study.

9 Mar 2017

Prostrate treatment may offer relief for patients with kidney stones

Millions of Australians suffering from kidney stones could soon get relief, with researchers discovering a prostrate treatment can also help ease the painful condition.

2 Nov 2016

Scientists identify new group of molecules that could slow tumour growth in prostate cancer patients

Prostate cancer patients have been offered hope after scientists at Newcastle University, UK, have identified a new group of molecules that could be targeted to slow tumour growth.

28 Jul 2016

Prostatic artery embolization improves sleep, quality of life for men with enlarged prostates

An innovative interventional radiology treatment for men with enlarged prostates decreases the number of times they wake to urinate in the night, according to research presented at the Society of Interventional Radiology's 2016 Annual Scientific Meeting. Researchers said the majority of men with enlarged prostates and lower urinary tract symptoms reported better sleep that resulted in an improved quality of life after they underwent a treatment called prostatic artery embolization (PAE).

4 Apr 2016

ANGLE’s Parsortix system may be used for detection of prostate cancer, Barts patient data suggests

ANGLE plc, the specialist medtech company, is delighted to announce that the results of Barts Cancer Institute’s ongoing work with ANGLE’s Parsortix system have provided evidence in support of the use of Parsortix in the detection and assessment of prostate cancer.

22 Mar 2016

Liverpool researchers reach major milestone towards creating diagnostic test for prostate cancer

A research team from the University of Liverpool has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.

12 Feb 2016

UVA opens clinical trial to examine non-surgical treatment for lower urinary tract symptoms

University of Virginia Health System researchers have opened a national clinical trial examining a non-surgical treatment for lower urinary tract symptoms caused by an enlarged prostate.

30 Nov 2015

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that STIOLTO RESPIMAT (tiotropium bromide and olodaterol) Inhalation Spray is now available by prescription at pharmacies across the United States.

30 Jun 2015

The Miriam Hospital offers new surgical treatment for benign prostatic hyperplasia

The Minimally Invasive Urology Institute at The Miriam Hospital is offering UroLift as one of the newest surgical treatments available for men with benign prostatic hyperplasia (BPH), an enlarged prostate condition.

23 Jun 2015

Cost of care for benign prostate hyperplasia measured for the first time

UCLA researchers have for the first time described cost across an entire care process for a common condition called benign prostate hyperplasia (BPH) using time-driven activity-based costing. They found a 400 percent discrepancy between the least and most expensive ways to treat the condition.

11 Mar 2015

Breakthrough treatment option for men with benign prostatic hyperplasia

Men with benign prostatic hyperplasia (BPH), a condition in which the prostate is enlarged but not cancerous, have a new, breakthrough treatment option that is less invasive and has fewer complications than other minimally invasive treatments, such as transurethral resection of the prostate and surgical options, according to research presented at the Society of Interventional Radiology's Annual Scientific Meeting.

3 Mar 2015

NICE recommends transurethral resection in saline system as the new gold standard for transurethral resection of the prostate

New guidance has been released today by the National Institute for Health and Care Excellence (NICE) recommending Olympus Medical’s transurethral resection in saline (TURis) system for use in surgery to reduce the size of enlarged prostate glands in men. NICE published the guidance in light of the potential it offers NHS hospitals to realise substantial cost savings of £285-£375 per patient whilst also improving patient outcomes.

From Evident Corporation - Life Sciences 27 Feb 2015

Men with BPH need to discuss 'male orgasmic dysfunction' with doctors prior to any treatment

NeoTract, Inc., today welcomes the publication of a paper in the British Journal of Urology International which calls for men suffering from enlarged prostate to discuss with their doctors the likely impact of treatment options on their sexual function. Most procedures and many medications can cause sexual dysfunction. Clinical studies show that treatment with the UroLift system has not been associated with any new onset of sustained ejaculatory or erectile dysfunction.

31 Oct 2014

Enlarged Prostate News and Research

UNC-Chapel Hill researchers find undesirable issues with widely-used drug screening tool

Use of 5ARIs for prostatic enlargement not linked to increased suicide risk in older men

Remnant fetal tissue could contribute to enlarged prostate in later life

Prolonged exposure to male hormone blockers increases risk of persistent erectile dysfunction

Prostrate treatment may offer relief for patients with kidney stones

Scientists identify new group of molecules that could slow tumour growth in prostate cancer patients

Prostatic artery embolization improves sleep, quality of life for men with enlarged prostates

ANGLE’s Parsortix system may be used for detection of prostate cancer, Barts patient data suggests

Liverpool researchers reach major milestone towards creating diagnostic test for prostate cancer

UVA opens clinical trial to examine non-surgical treatment for lower urinary tract symptoms

STIOLTO RESPIMAT Inhalation Spray now available for treatment of COPD across the U.S.

The Miriam Hospital offers new surgical treatment for benign prostatic hyperplasia

Cost of care for benign prostate hyperplasia measured for the first time

Breakthrough treatment option for men with benign prostatic hyperplasia

NICE recommends transurethral resection in saline system as the new gold standard for transurethral resection of the prostate

Men with BPH need to discuss 'male orgasmic dysfunction' with doctors prior to any treatment

Physically active men are at lower risk of nocturia

ProMedica participates in innovative research into development of non-invasive treatment for BPH

Death rate increases with hospitals shift from inpatient procedures to outpatient for urological surgeries

Prostate cancer breakthroughs offer new hope for men

What to know about prostate cancer eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News